Femmepap

Active substance: THUJA OCCIDENTALIS LEAFY TWIG, NITRIC ACID, CAUSTICUM, JUNIPERUS SABINA LEAFY TWIG, ALCOHOL, X-RAY EXPOSED (1000 RAD), ANTIMONY PENTASULFIDE, HUMAN PAPILLOMAVIRUS, HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN

SPRAY · THUJA OCCIDENTALIS LEAFY TWIG 4 [hp_X]/mL, NITRIC ACID 6 [hp_X]/mL, CAUSTICUM 6 [hp_X]/mL, JUNIPERUS SABINA LEAFY TWIG 6 [hp_X]/mL, ALCOHOL, X-RAY EXPOSED (1000 RAD) 15 [hp_X]/mL, ANTIMONY PENTASULFIDE 18 [hp_X]/mL, HUMAN PAPILLOMAVIRUS 20 [hp_X]/mL, HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN 20 [hp_C]/mL

United StatesActive

Marketing holder: Nutritional Specialties, Inc.

Verified 2026-10-09 · openFDA NDC

Source: openFDA NDC
Countries with the substance registered: 1

Composition

THUJA OCCIDENTALIS LEAFY TWIG · 4 [hp_X]/mL
NITRIC ACID · 6 [hp_X]/mL
CAUSTICUM · 6 [hp_X]/mL
JUNIPERUS SABINA LEAFY TWIG · 6 [hp_X]/mL
ALCOHOL, X-RAY EXPOSED (1000 RAD) · 15 [hp_X]/mL
ANTIMONY PENTASULFIDE · 18 [hp_X]/mL
HUMAN PAPILLOMAVIRUS · 20 [hp_X]/mL
HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN · 20 [hp_C]/mL

Registration

Registration number: 83027-0005
Registration status: Active
Dispensing: Over the counter
Route: ORAL

Sources

product · openFDA NDC · 83027-0005 · Verified 2026-10-09 · open in source
registration_status · openFDA NDC · 83027-0005 · Verified 2026-10-09 · open in source
ingredients.0 · openFDA NDC · 83027-0005 · Verified 2026-10-09 · open in source
ingredients.1 · openFDA NDC · 83027-0005 · Verified 2026-10-09 · open in source
ingredients.2 · openFDA NDC · 83027-0005 · Verified 2026-10-09 · open in source
ingredients.3 · openFDA NDC · 83027-0005 · Verified 2026-10-09 · open in source
ingredients.4 · openFDA NDC · 83027-0005 · Verified 2026-10-09 · open in source
ingredients.5 · openFDA NDC · 83027-0005 · Verified 2026-10-09 · open in source
ingredients.6 · openFDA NDC · 83027-0005 · Verified 2026-10-09 · open in source
ingredients.7 · openFDA NDC · 83027-0005 · Verified 2026-10-09 · open in source